Concerto Biosciences

Concerto Biosciences

Verified
Discovers and develops microbial ensembles: specific combinations of microbes that, by working in concert, accomplish useful functions in human health, agriculture, and industry.

Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$600—900k (Dealroom.co estimates Dec 2020.)
Cambridge Massachusetts (HQ)
  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor

$0.0

round

$150k

Seed
Total Funding000k

Recent News about Concerto Biosciences

Edit